A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic

Vaccine

Volumn 28, Issue 31, 2010, Pages 4875-4879

  Lee, Bruce Y ^a   Brown, Shawn T ^a,b   Korch, George W ^c   Cooley, Philip C ^d   Zimmerman, Richard K ^a   Wheaton, William D ^d   Zimmer, Shanta M ^a   Grefenstette, John J ^a   Bailey, Rachel R ^a   Assi, Tina Marie ^a   Burke, Donald S ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b PITTSBURGH SUPERCOMPUTING CENTER   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d RTI INTERNATIONAL   (United States)

Author keywords

Influenza; Pandemic; Vaccines

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CITY; COMPUTER SIMULATION; HEALTH CARE POLICY; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; PANDEMIC; PRIORITY JOURNAL; RESOURCE ALLOCATION; VACCINE PRODUCTION; CHILD; DISEASE OUTBREAKS; HEALTH CARE ORGANIZATION; INFLUENZA, HUMAN; SUPPLY AND DISTRIBUTION;

CHILD; COMPUTER SIMULATION; DISEASE OUTBREAKS; HEALTH CARE RATIONING; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN;

EID: 77954758346     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.05.002     Document Type: Article

References (34)

1. Schultz E.D., Tanaka D.T., Goldberg R.N., Benjamin D.K., Smith P.B. Effect of methicillin-resistant Staphylococcus aureus colonization in the neonatal intensive care unit on total hospital cost. Infect Control Hosp Epidemiol 2009, (February).
2. Medlock J., Galvani A.P. Optimizing influenza vaccine distribution. Science 2009, 325(September (5948)):1705-1708.
3. Ferguson N.M., Cummings D.A., Fraser C., Cajka J.C., Cooley P.C., Burke D.S. Strategies for mitigating an influenza pandemic. Nature 2006, 442(July (7101)):448-452.
4. Halloran M.E., Ferguson N.M., Eubank S., Longini I.M., Cummings D.A., Lewis B., et al. Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci USA 2008, 105(March (12)):4639-4644.
5. Lee B.Y., Brown S.T., Cooley P.C., Zimmerman R.K., Wheaton W.D., Zimmer S.M., et al. A computer simulation of employee vaccination to mitigate an influenza epidemic. Am J Prev Med 2010, 38(March (3)):247-257.
6. Wheaton W., Cajka J., Chasteen B., Wagener D., Cooley P., Ganapathi L., et al. A US Geospatial Database for Agent-Based Models 2009, RTI International: RTI Press, NC. R.T. Park (Ed.).
7. Beckman R.J., Baggerly K.A., McKay M.D. Creating synthetic baseline populations. Transport Res a-Pol. 1996, 30(November (6)):415-429.
8. Eubank S., Guclu H., Kumar V.S., Marathe M.V., Srinivasan A., Toroczkai Z., et al. Modeling disease outbreaks in realistic urban social networks. Nature 2004, 429(May (6988)):180-184.
9. Ferguson N.M., Cummings D.A., Cauchemez S., Fraser C., Riley S., Meeyai A., et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005, 437(September (7056)):209-214.
10. Cooley P., Lee B.Y., Brown S., Cajka J., Chasteen B., Ganapathi L., et al. Protecting health care workers: a pandemic simulation based on Allegheny County. Influenza Other Respi Viruses 2010, 4(March (2)):61-72.
11. Germann T., Kadau K., Longini I.J., Macken C. Mitigation strategies for pandemic influenza in the United States. PNAS 2006, (April).
12. Bootsma M.C., Ferguson N.M. The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Proc Natl Acad Sci USA 2007, 104(May (18)):7588-7593.
13. Longini I., Halloran E., Nizam A., Yang Y. Containing pandemic influenza with antiviral agents. Am J Epidemiol 2004, 159:623-633.
14. Shi P., Keskinocak P., Swann J.L., Lee B.Y. Modelling seasonality and viral mutation to predict the course of an influenza pandemic. Epidemiol Infect 2010, 17(February):1-10.
15. Beigi R.H., Wiringa A.E., Bailey R.R., Assi T.M., Lee B.Y. Economic value of seasonal and pandemic influenza vaccination during pregnancy. Clin Infect Dis 2009, 49(December (12)):1784-1792.
16. Lee B.Y., Ercius A.K., Smith K.J. A predictive model of the economic effects of an influenza vaccine adjuvant for the older adult (age 65 and over) population. Vaccine 2009, 27(April (16)):2251-2257.
17. Lee B.Y., Mehrotra A., Burns R.M., Harris K.M. Alternative vaccination locations: who uses them and can they increase flu vaccination rates?. Vaccine 2009, 27(July (32)):4252-4256.
18. Lee B.Y., Tai J.H., Bailey R.R., Smith K.J. The timing of influenza vaccination for older adults (65 years and older). Vaccine 2009, 27(November (50)):7110-7115.
19. Lee B.Y., Tai J.H., Bailey R.R., Smith K.J., Nowalk A.J. Economics of influenza vaccine administration timing for children. Am J Manag Care 2010, 16(March (3)):e75-e85.
20. Lee B.Y., Brown S.T., Cooley P., Potter M.A., Wheaton W.D., Voorhees R.E., et al. Simulating school closure strategies to mitigate an influenza epidemic. J Public Health Manag Pract 2010, 16(May-June (3)):252-261.
21. Longini I., Nizam A., Xu S., Undchusak K., Hanshaoworakul W., Cummings D., et al. Containing pandemic influenza at the source. Science 2005, 309:1083-1089.
22. Weycker D., Edelsberg J., Halloran M., Longini I., Ciuryla V., Oster G. Population-wide benefits of routine vaccination of children against influenza. Vaccine 2005, 23(10):1284-1293.
23. Li G., Yilmaz M., Kojicic M., Fernandez-Perez E., Wahab R., Huskins W., et al. Outcome of critically ill patients with influenza virus infection. J Clin Virol 2009, 46(November (3)):275-278.
24. Fraser C., Donnelly C.A., Cauchemez S., Hanage W.P., Van Kerkhove M.D., Hollingsworth T.D., et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 2009, 324(June (5934)):1557-1561.
25. Red Book. 2009 ed. Montvale, NJ: Thompson Healthcare Inc., 2009.
26. Zhang X., Meltzer M., Wortley P. FluSurge-a tool to estimate demand for hospital services during the next pandemic influenza. Med Decis Making 2006, 26:617-623.
27. Merler S., Ajelli M., Rizzo C. Age-prioritized use of antivirals during an influenza pandemic. BMC Infect Dis 2009, 9(117):1-13.
28. Matheson N., Harnden A., Perera R., Sheikh A., Symmonds-Abrahams M. Neuraminidase inhibitors for preventing and treating influenza in children (Review). Cochrane Collab 2007, 1:1-53.
29. Age Groups and Sex: 2000. US Census Bureau: American FactFinder 2000; Available from: [cited 2009 19 October]. http://factfinder.census.gov/servlet/QTTable%3F_bm=y%26-qr_name=DEC_2000_SF1_U_QTP1%26-geo_id=01000US%26-ds_name=DEC_2000_SF1_U%26-_lang=en%26-format=%26-currentselections=DEC_2000_SF1_U_QTP1%26-CONTEXT=qt.
30. Presanis A., lIPSitch M., Angelis D.D. The severity of pandemic H1N1 influenza in the United States, April-July 2009. PLoS Curr Influenza 2009, (September). [revised 2009 Oct 2]:RRN1042 2009;Version 3.
31. Cases of HIV infection and AIDS in the United States and dependent areas, 2007. HIV/AIDS Surveillance Report 2007; 19.
32. Summary Health Statistics for the US Population: National Health Interview Survey, 2006. Washington DC; 2006.
33. Basta N., Halloran M., Matrajt L., Longini I. Estimating influenza vaccine efficacy from challenge and community-based study data. Am J Epidemiol 2008, 168(12):1343-1352.
34. Greensburg M., Lai M., Hartel G., Wichems C., Gittleson C., Bennet J., et al. Response after one dose of a monovalent influenza A(H1N1) 2009 vaccine - preliminary report. N Engl J Med 2009, 361.